Leadership Overview
Granules has 8 executives leading key functions including strategy, operations, technology, finance, human resources, API manufacturing, and portfolio management.
Driven by customer centricity, Granules manufactures high-quality API, FD, PFI and Speciality Products, impacting global pharmaceutical markets through its integrated approach.
Driven by customer centricity, Granules manufactures high-quality API, FD, PFI and Speciality Products, impacting global pharmaceutical markets through its integrated approach.
Leadership Roles at Granules
Venu Babu - Chief Executive Officer
Venu Babu, the Chief Executive Officer at Granules, directs the company's overall strategic vision and operational execution. Overseeing all business units, Babu ensures alignment with Granules' mission of manufacturing high-quality pharmaceutical products. This leadership role involves driving growth initiatives and maintaining Granules' position as a vertically integrated, high-growth pharmaceutical manufacturer. Babu's focus remains on enhancing customer centricity and expanding market reach. By optimizing resource allocation and fostering innovation, Venu Babu directly contributes to the company's sustained success and its impact on global healthcare. The Chief Executive Officer's guidance shapes the company's trajectory in the competitive pharmaceutical landscape.
Mukesh Surana - Global Chief Financial Officer
Mukesh Surana, the Global Chief Financial Officer at Granules, directs the company's financial strategy, planning, and reporting. Surana oversees all financial operations, including budgeting, forecasting, and capital management, ensuring fiscal health and sustainable growth. This leadership position is critical for managing Granules' financial performance and supporting its global expansion. By optimizing financial resources and mitigating risks, Mukesh Surana directly contributes to the company's profitability and shareholder value. The Global Chief Financial Officer's insights guide strategic investment decisions and ensure compliance with financial regulations. Surana's expertise is fundamental to Granules' integrated business model.
Jai Velusamy - Chief Operating Officer
Jai Velusamy, the Chief Operating Officer at Granules, manages the day-to-day operational activities across all manufacturing facilities. Velusamy ensures efficient production of high-quality API, FD, PFI, and Speciality Products, adhering to stringent quality standards. This role involves optimizing supply chain logistics and enhancing operational workflows to support Granules' high-growth trajectory. By driving process improvements and resource management, Jai Velusamy directly supports the company's customer-centric approach. The Chief Operating Officer's oversight guarantees seamless integration between different production stages, reinforcing Granules' vertically integrated model. Velusamy's leadership ensures operational excellence and consistent product delivery.
Pranesh Mathur - President API
Pranesh Mathur, the President API at Granules, leads the Active Pharmaceutical Ingredient (API) manufacturing division. Mathur oversees the production, quality control, and supply chain management for all API products, ensuring adherence to global regulatory standards. This role is pivotal in maintaining Granules' strength as a vertically integrated manufacturer. By driving operational excellence and innovation within the API segment, Pranesh Mathur directly supports the company's product portfolio and customer commitments. The President API's strategic direction ensures the consistent delivery of high-quality APIs, crucial for downstream pharmaceutical formulations. Mathur's leadership reinforces Granules' market position.
Vijay Raghavan - Global President, Portfolio
Vijay Raghavan, the Global President, Portfolio at Granules, spearheads the strategic development and management of the company's product portfolio. Raghavan identifies market opportunities and drives innovation across Granules' offerings, including API, FD, PFI, and Speciality Products. This leadership role involves aligning product strategy with market demands and ensuring a competitive edge. By fostering cross-functional collaboration, Vijay Raghavan directly contributes to the expansion and diversification of Granules' product lines. The Global President, Portfolio's vision shapes the future product pipeline and reinforces Granules' commitment to customer centricity. Raghavan's expertise is key to sustained market relevance.
Srinivas Pv - Chief Technology Officer
Srinivas Pv, the Chief Technology Officer at Granules, architects the company's technological infrastructure and innovation roadmap. Pv oversees the implementation of advanced technologies across manufacturing and R&D, ensuring Granules remains at the forefront of pharmaceutical production. This leadership position involves driving digital transformation initiatives and enhancing data security protocols. By leveraging cutting-edge solutions, Srinivas Pv directly supports the development of new pharmaceutical products and improves operational efficiency. The Chief Technology Officer's strategic direction ensures that Granules' technological capabilities align with its growth objectives and customer needs. Pv's expertise is critical for maintaining a competitive edge in the industry.
Sriram Chavali - EA-Chief of Staff, Directorate
Sriram Chavali, the EA-Chief of Staff, Directorate at Granules, provides strategic support and operational coordination for the executive leadership team. Chavali facilitates communication and drives key initiatives across various departments, ensuring seamless execution of directorial directives. This role involves managing cross-functional projects and optimizing internal processes to enhance organizational efficiency. By acting as a central point of contact, Sriram Chavali directly supports the strategic objectives of Granules. The EA-Chief of Staff's involvement ensures that the Directorate's vision is effectively translated into actionable plans. Chavali's contributions are vital for maintaining operational synergy and driving forward the company's mission.
Vinod Parur - Chief Human Resources Officer
Vinod Parur, the Chief Human Resources Officer at Granules, leads the company's human capital strategy and talent management initiatives. Parur oversees recruitment, employee development, and organizational culture, ensuring a motivated and skilled workforce. This role is crucial for supporting Granules' high-growth objectives and fostering a customer-centric environment. By implementing effective HR policies and programs, Vinod Parur directly contributes to employee engagement and retention. The Chief Human Resources Officer's leadership ensures that Granules attracts and retains top talent, essential for its continued success in the pharmaceutical sector. Parur's focus is on building a robust organizational foundation.

Explore Leadership Teams in Manufacturing
Tolmar Pharmaceuticals is a fully integrated pharmaceutical company focused on the innovative development, manufacturing, and commercialization of specialty pharmaceuticals across multiple therapeutic areas, including Urology. Tolmar global headquarters, product development and manufacturing facilities are based in Northern Colorado, while North America commercial headquarters is based in Buffalo Grove, Illinois.
Company Leadership AD
AC
SS
Madrigal Pharmaceuticals, Inc, a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. The company's lead candidate is MGL-3196, an orally administered, small-molecule, liver-directed, thyroid hormone receptor (THR) -selective agonist, which is in Phase II clinical trials for the treatment of non-alcoholic steatohepatitis and heterozygous familial hypercholesterolemia.
Company Leadership
RF
CW
SK
TriRx Pharmaceuticals is a contract development and manufacturing organization specializing in both non-sterile and sterile products, including animal health injectables and packaging solutions. The company offers a wide range of capabilities such as development and analytics, sterile and non-sterile manufacturing, and packaging services. With facilities located in Huntsville, Alabama, and Segré, France, TriRx aims to support customers' commercialization efforts across global markets. Their target clients include pharmaceutical companies looking for advanced solutions to bring their products to market.
Company Leadership TT
JS
SH
KL
Founded in 1987, Integrated DNA Technologies, Inc. headquartered in Coralville, Iowa, is the supplier of custom nucleic acids, serving the areas of academic research, biotechnology, clinical diagnostics, and pharmaceutical development. The company develops, manufactures, and markets nucleic acid products for the life sciences industry.
Company Leadership AA
CL
AG
AM